Ignite Creation Date:
2024-05-06 @ 3:43 AM
Last Modification Date:
2024-10-26 @ 11:37 AM
Study NCT ID:
NCT02353039
Status:
UNKNOWN
Last Update Posted:
2015-07-03
First Post:
2015-01-27
Brief Title:
Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Sponsor:
Green Cross Corporation
Organization:
GC Biopharma Corp
Study Overview
Official Title:
Double Blind Multicenter Randomized Placebo-controlled Parallel-group Phase II Study to Evaluate the Efficacy and Safety of GC6101A in Subjects With Gastritis
Status:
UNKNOWN
Status Verified Date:
2015-07
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of the investigational products in the patients with gastritis during their participation in the study
Detailed Description:
GC6101A is botanical drug products made from the Lonicerae Flos Two hundred volunteers will participate in the study receive 2-week treatment with GC6101A or placebo
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None